Major depression and treatment response in adolescents with ADHD and substance use disorder
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Background Major depressive disorder (MDD) frequently co-occurs in adolescents with substance use disorders (SUD) and attention deficit hyperactivity disorder (ADHD), but the impact of MDD on substance treatment and ADHD outcomes and implications for clinical practice are unclear. Methods Adolescents (n=303; ages 13-18) meeting DSM-IV criteria for ADHD and SUD were randomized to Osmotic Release Methylphenidate (OROS-MPH) or placebo and 16 weeks of cognitive behavioral therapy (CBT). Adolescents with (n=38) and without (n=265) MDD were compared on baseline demographic and clinical characteristics as well as non-nicotine substance use and ADHD treatment outcomes. Results Adolescents with MDD reported more non-nicotine substance use days at baseline and continued using more throughout treatment compared to those without MDD (p<0.0001 based on Timeline Followback; p<0.001 based on urine drug screens). There was no difference between adolescents with and without MDD in retention or CBT sessions attended. ADHD symptom severity (based on DSM-IV ADHD Rating Scale) followed a slightly different course of improvement although with no difference between groups in baseline or 16-week symptom severity or 16 week symptom reduction. There was no difference in days of substance use or ADHD symptom outcomes over time in adolescents with MDD or those without MDD treated with OROS-MPH or placebo. Depressed adolescents were more often female, older, and not court ordered. Conclusions These preliminary findings suggest that compared to non-depressed adolescents with ADHD and SUD, those with co-occurring MDD have more severe substance use at baseline and throughout treatment. Such youth may require interventions targeting depression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gmel, G., & Rehm, J. (2004) · Contemporary Drug Problems · doi:10.1177/009145090403100304 · Cited by 466
Chan, Y.-F., Dennis, M. L., & Funk, R. R. (2008) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2006.12.031 · Cited by 443
Drug treatment outcomes for adolescents with comorbid mental and substance use disorders
GRELLA, C. E., HSER, Y.-I., JOSHI, V., & ROUNDS-BRYANT, J. (2001) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-200106000-00006 · Cited by 379
Maude-Griffin, P. M., Hohenstein, J. M., Humfleet, G. L., Reilly, P. M., Tusel, D. J., & Hall, S. M. (1998) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.66.5.832 · Cited by 162
Psychostimulants for depression
Candy, B., Jones, L., Williams, R., Tookman, A., & King, M. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006722.pub2 · Cited by 156 · cited 1×
“While there is some evidence for the efficacy of psychostimulants in reducing symptoms of depression (Candy et al., 2008), the finding that substance use outcomes do not differ with its use in the adolescents with MDD is consistent with the prior studies that found psychopharmacology for depression…”
ResultKratochvil, C. J., Newcorn, J. H., Arnold, L. E., Duesenberg, D., Emslie, G. J., Quintana, H., Sarkis, E. H., Wagner, K. D., Gao, H., & Michelson, D. (2005) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000169012.81536.38 · Cited by 152
Riggs, P. D., Winhusen, T., Davies, R. D., Leimberger, J. D., Mikulich-Gilbertson, S., Klein, C., Macdonald, M., Lohman, M., Bailey, G. L., Haynes, L., et al. (2011) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2011.06.010 · Cited by 124
Self-citationDouble-blind fluoxetine trial in comorbid MDD-CUD youth and young adults.
Cornelius, J. R., Bukstein, O. G., Douaihy, A. B., Clark, D. B., Chung, T. A., Daley, D. C., Wood, D. S., & Brown, S. J. (2010) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2010.05.010 · Cited by 105 · cited 4×
“Similarly, in an RCT of fluoxetine versus placebo in adolescents and young adults (n=70) with MDD and cannabis use disorder (CUD), receiving MET and CBT for depression and CUD, reductions in depression did not differ between groups and amount of cannabis use did not improve significantly in either group (Cornelius et…”
BackgroundMethodResultInfluential
Cited by
Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD)
Storebø, O. J., Ramstad, E., Krogh, H. B., Nilausen, T. D., Skoog, M., Holmskov, M., Rosendal, S., Groth, C., Magnusson, F. L., Moreira-Maia, C. R., et al. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009885.pub2 · Cited by 347
Molina, B. S. G., & Pelham, W. E. (2014) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-032813-153722 · Cited by 186
Attention-Deficit/Hyperactivity Disorder and Substance Abuse
Harstad, E., Levy, S., COMMITTEE ON SUBSTANCE ABUSE, Levy, S., Ammerman, S. D., Gonzalez, P. K., Ryan, S. A., Siqueira, L. M., & Smith, V. C. (2014) · Pediatrics · doi:10.1542/peds.2014-0992 · Cited by 131
Alcohol use disorders and ADHD.
Luderer, M., Ramos Quiroga, J. A., Faraone, S. V., Zhang-James, Y., & Reif, A. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.07.010 · Cited by 102
Katzman, M., & Sternat, T. (2016) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s111818 · Cited by 83
Metadata
- Authors
- Warden, D., Riggs, P. D., Min, S.-J., Mikulich-Gilbertson, S. K., Tamm, L., Trello-Rishel, K., & Winhusen, T.
- Venue
- Drug and Alcohol Dependence
- Publisher
- Elsevier BV
- Published
- 2012-01
- Volume
- 120
- Issue
- 1-3
- Pages
- 214-219
- ISSN
- 0376-8716 (ISSN-L)
- OpenAlex
- W1968257213
- Cited by
- 34
- References
- 8
- FWCI
- 1.58
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Major depression and treatment response in adolescents with ADHD and substance use disorder. https://app.cochat.ai/papers/10.1016/j.drugalcdep.2011.08.001
- The paper
- Warden, D., Riggs, P. D., Min, S.-J., Mikulich-Gilbertson, S. K., Tamm, L., Trello-Rishel, K., & Winhusen, T. (2012). Major depression and treatment response in adolescents with ADHD and substance use disorder. Drug and Alcohol Dependence. https://doi.org/10.1016/j.drugalcdep.2011.08.001
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.